Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

Dr. Nuala Murphy has been appointed as executive vice president of global clinical operations and data management. Murphy has over 20 years of experience within the pharmaceutical and CRO industries. She most recently served at Quintiles, where she managed clinical research professionals in Europe and Africa in her role as vice president of clinical operations. Murphy also has over a decade of experience in therapeutics having led the CNS and internal medicine project management divisions for Quintiles.

Dr. Mark Roseman has been appointed as executive vice president of global scientific operations. He joins Icon with over 25 years of clinical research experience. Prior to Icon, Roseman served as executive vice president of business development at Kendle/INC. He also held senior management positions in both operations and business development at PPD and supervised the oncology, cardiovascular, anti-infective and respiratory therapeutic areas. Previously, Roseman supervised all data management, clinical operations, biostatistics and medical writing activities at CIBA Vision and was responsible for the conduct of their registration trials.

Dr. Era Khurana has joined Icon’s central laboratories’ leadership team as medical director. She will provide scientific leadership and guidance and drive standards of performance and quality at Icon’s laboratories in Farmingdale, N.Y.; Dublin, Ireland; Bangalore, India and Singapore. Khurana has over 28 years of pathology experience and joins Icon from Quest Diagnostics, where she served as director of anatomical and clinical pathology. Previously, she served as chief of surgical pathology at South Nassau Community Hospital in New York.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs